Get started
Author

Gulam Abbas Manji

Observed names: G A Manji, G Manji, G. A. Manji, G. Manji, G.A. Manji, Gulam A. Manji, Gulam A Manji, Gulam A. Manji, Gulam A. Manji (15425575), Gulam Manji, Manji, Gulam, Manji, Gulam A, Manji, Gulam A.
Observed institutions: University of North Carolina at Chapel Hill, Westchester Medical Center, Memorial Sloan Kettering Cancer Center, NewYork–Presbyterian Hospital, University of Wisconsin–Madison, Harvard University, University of Cape Town, Columbia University Irving Medical Center, Albany Stratton VA Medical Center Albany, Herbert Irving Comprehensive Cancer Center, Takeda Oncology (United States), Albany Medical Center Hospital, Columbia University
ORCID: 0000-0001-9817-2414
Observed ORCIDs: 0000-0001-9817-2414, 0009-0000-7459-6036
OpenAlex ID: A5021028061
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
2018 · Andrew X Zhu, Richard S Finn, et al. · The Lancet Oncology · 2,474
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
2020 · Michael S Lee, Baek-Yeol Ryoo, et al. · The Lancet Oncology · 562
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2023 · Shukui Qin, Minshan Chen, et al. · The Lancet · 538
PDF
PYPAF7, a Novel PYRIN-containing Apaf1-like Protein That Regulates Activation of NF-κB and Caspase-1-dependent Cytokine Processing
2002 · Lin Wang, Gulam A. Manji, et al. · Journal of Biological Chemistry · 372
Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF‐κB and caspase‐1
2002 · Jill M. Grenier, Lin Wang, et al. · FEBS Letters · 296
PYPAF1, a PYRIN-containing Apaf1-like Protein That Assembles with ASC and Regulates Activation of NF-κB
2002 · Gulam A. Manji, Lin Wang, et al. · Journal of Biological Chemistry · 278
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
2024 · Urszula N. Wasko, Jingjing Jiang, et al. · Nature · 205
CARD10 Is a Novel Caspase Recruitment Domain/Membrane-associated Guanylate Kinase Family Member That Interacts with BCL10 and Activates NF-κB
2001 · Lin Wang, Yin Guo, et al. · Journal of Biological Chemistry · 147
Current and Emerging Therapies in Metastatic Pancreatic Cancer
2017 · Gulam Abbas Manji, Kenneth P. Olive, et al. · Clinical Cancer Research · 145
Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
2022 · Margaret A. Tempero, Uwe Pelzer, et al. · Journal of Clinical Oncology · 143
PDF
Human CARD12 Is a Novel CED4/Apaf-1 Family Member That Induces Apoptosis
2001 · Brad J. Geddes, Lin Wang, et al. · Biochemical and Biophysical Research Communications · 121
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
2026 · Eileen M. O’Reilly, Zev A. Wainberg, et al. · New England Journal of Medicine · 116
BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects
2020 · Winston Wong, Alexander G Raufi, et al. · Cancer Management and Research · 109
PDF
Neoadjuvant Treatment for Pancreatic Cancer
2018 · Alexander G. Raufi, Gulam A. Manji, et al. · Seminars in Oncology · 97
Baculovirus inhibitor of apoptosis functions at or upstream of the apoptotic suppressor P35 to prevent programmed cell death
1997 · G A Manji, R R Hozak, et al. · Journal of Virology · 94
Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment
2021 · Anna M. Chiarella, Yun K. Ryu, et al. · Trends in cancer · 83
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
2024 · Neil H. Segal, Ignacio Melero, et al. · Nature Communications · 76
Proteolytic Release of Membrane-Bound Angiotensin-Converting Enzyme: Role of the Juxtamembrane Stalk Sequence
1996 · Mario R. W. Ehlers, Sylva L. U. Schwager, et al. · Biochemistry · 69
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform
2023 · Andrew H Ko, Kyu-Pyo Kim, et al. · The Oncologist · 61
PDF
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
2020 · Tamas A. Gonda, Jarwei Fang, et al. · Cancer Research · 60
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
2021 · Gulam A. Manji, Brian A. Van Tine, et al. · Clinical Cancer Research · 59
The BIR Motifs Mediate Dominant Interference and Oligomerization of Inhibitor of Apoptosis Op-IAP
2000 · Rebecca R. Hozak, Gulam A. Manji, et al. · Molecular and Cellular Biology · 56
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
2020 · Lipika Goyal, Cynthia Sirard, et al. · Clinical Cancer Research · 55
PDF
Apoptosis in Motion
2001 · Gulam A. Manji, Paul D. Friesen · Journal of Biological Chemistry · 55
PDF
A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2023 · Prabhjot S. Mundi, Filemon S. Dela Cruz, et al. · Cancer Discovery · 50
PDF
Works count: 249
Citation count: 7,141
H-index: 29
I10-index: 57
Year
Topic
Type